184 related articles for article (PubMed ID: 10527351)
41. Comparison of long-term oncological outcomes of appendiceal cancer and colon cancer: A multicenter retrospective study.
Son IT; Ahn S; Park KJ; Oh JH; Jeong SY; Park HC; Heo SC; Youk EG; Park JT; Ihn MH; Oh HK; Kim DW; Lee KH; Kang SB;
Surg Oncol; 2016 Mar; 25(1):37-43. PubMed ID: 26979639
[TBL] [Abstract][Full Text] [Related]
42. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients.
Esquivel J; Sugarbaker PH
Ann Surg; 2001 Aug; 234(2):198-205. PubMed ID: 11505065
[TBL] [Abstract][Full Text] [Related]
43. [Cytoreductive surgery with intraperitoneal chemotherapy in patients with colon cancer and peritoneal carcinomatosis].
Zhuchenko AP; Kalganov ID; Filon AF
Antibiot Khimioter; 2003; 48(1):31-5. PubMed ID: 12741321
[TBL] [Abstract][Full Text] [Related]
44. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
[TBL] [Abstract][Full Text] [Related]
45. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
[TBL] [Abstract][Full Text] [Related]
46. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
[TBL] [Abstract][Full Text] [Related]
47. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
[TBL] [Abstract][Full Text] [Related]
48. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
[TBL] [Abstract][Full Text] [Related]
49. Hyperthermic intraperitoneal chemoperfusion is an option for treatment of peritoneal carcinomatosis in children.
Reingruber B; Boettcher MI; Klein P; Hohenberger W; Pelz JO
J Pediatr Surg; 2007 Sep; 42(9):E17-21. PubMed ID: 17848227
[TBL] [Abstract][Full Text] [Related]
50. The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre.
Ung L; Chua TC; Morris DL
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1037-45. PubMed ID: 24652408
[TBL] [Abstract][Full Text] [Related]
51. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection.
Grotz TE; Overman MJ; Eng C; Raghav KP; Royal RE; Mansfield PF; Mann GN; Robinson KA; Beaty KA; Rafeeq S; Matamoros A; Taggart MW; Fournier KF
Ann Surg Oncol; 2017 Sep; 24(9):2646-2654. PubMed ID: 28695394
[TBL] [Abstract][Full Text] [Related]
52. Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin.
Evers DJ; Verwaal VJ
Br J Surg; 2011 Feb; 98(2):287-92. PubMed ID: 21046680
[TBL] [Abstract][Full Text] [Related]
53. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
[TBL] [Abstract][Full Text] [Related]
54. Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy.
Liberale G; Elias D; Sideris L; Lasser P; Malka D; Sabourin JC; Pocard M
J Surg Oncol; 2005 Jul; 91(1):73-6. PubMed ID: 15999360
[TBL] [Abstract][Full Text] [Related]
55. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
[TBL] [Abstract][Full Text] [Related]
56. Analysis of patient selection policy and pattern of recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis.
Robella M; Vaira M; Borsano A; DE Simone M
Minerva Chir; 2018 Apr; 73(2):133-141. PubMed ID: 29397633
[TBL] [Abstract][Full Text] [Related]
57. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix.
Elias D; Glehen O; Pocard M; Quenet F; Goéré D; Arvieux C; Rat P; Gilly F;
Ann Surg; 2010 May; 251(5):896-901. PubMed ID: 20395843
[TBL] [Abstract][Full Text] [Related]
58. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
Chua TC; Quinn LE; Zhao J; Morris DL
J Surg Oncol; 2013 Aug; 108(2):81-8. PubMed ID: 23737041
[TBL] [Abstract][Full Text] [Related]
59. Phase II study of regional treatment for peritoneal carcinomatosis.
Lanuke K; Mack LA; Temple WJ
Am J Surg; 2009 May; 197(5):614-8; discussion 618. PubMed ID: 19393354
[TBL] [Abstract][Full Text] [Related]
60. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
Sugarbaker PH
Lancet Oncol; 2006 Jan; 7(1):69-76. PubMed ID: 16389186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
